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This spike broadening was unaltered by acute application 
of homocysteine. However, it was significantly diminished 
when incubation with homocysteine was extended to 24 h 
prior to recording. Furthermore, the number of action poten-
tials elicited by low current injections was reduced after 
long-term incubation with homocysteine, but not by the 
acute application. After 24 h of homocysteine incubation, 
the input resistance was reduced which might have contrib-
uted to the observed alterations in membrane excitability. 
We conclude that homocysteine exposure causes changes 
in the intrinsic electrophysiological properties of cultured 
hippocampal neurons as a mechanism of neurological 
symptoms of hyperhomocysteinemia.
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Introduction
Homocysteine is a sulfur containing, reactive, non- 
proteinogenic amino acid occurring as ubiquitous inter-
mediate of methionine metabolism. Depending on the cell 
type, homocysteine can be metabolized within or released 
from the cell (Mudd et al. 2001). Several enzymes, trans-
porter proteins and transmembrane carriers are involved 
in methionine–homocysteine metabolism, in which folate, 
riboflavin, vitamin B6 and vitamin B12 act as co-factors. 
Several hereditary enzyme defects and vitamin deficien-
cies can cause severe hyperhomocysteinemia, in which 
disulfides of homocysteine form homocystine. Because 
homocystine is renally excreted, this metabolic condi-
tion is denominated homocystinuria (Mudd et al. 2001). 
Neurological symptoms associated with untreated homo-
cystinuria include psychomotor retardation, disturbances 
Abstract Homocystinuria is an inborn error of metabo-
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associated with vascular disease, cognitive impairment and 
neurodegeneration. Several mechanisms of homocysteine 
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tion on putative effects of hyperhomocysteinemia on the 
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effects, we examined primary cultures of mouse hippocam-
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cell cultures were incubated with 100 μM homocysteine 
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and prolonged current injections. Single action potentials 
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we elicited trains of action potentials with prolonged cur-
rent injections (200 ms), a broadening of action potentials 
during repetitive firing was observed in control neurons. 
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of central nervous system myelination and epilepsy (Mudd 
et al. 1985). Whereas homocysteine plasma levels in 
homocystinuria patients can reach 500 μM, mild hyperho-
mocysteinemia is defined by homocysteine plasma levels 
above the upper reference range of 10–15 μM up to 25 μM 
(Stanger et al. 2009). Polymorphic variants of proteins 
involved in homocysteine metabolism, vitamin deficien-
cies and renal dysfunction are common reasons of mild 
hyperhomocysteinemia (Mudd et al. 2001). Numerous 
studies investigated the relevance of mild hyperhomo-
cysteinemia for central nervous system disorders. Mild 
hyperhomocysteinemia is associated not only with cerebro-
vascular disease, but also with mild cognitive impairment, 
Alzheimer’s disease and epilepsy (Stanger et al. 2009). 
Moreover, the recent VITACOG trial showed a signifi-
cant reduction in brain atrophy as effect of homocysteine- 
lowering vitamins in individuals with mild cognitive 
impairment (Smith et al. 2010). Thus, a causal relation-
ship between homocysteine and neuronal damage may be 
assumed, but the underlying mechanisms remain specu-
lative. Homocysteine acts as a partial antagonist of the 
glycine site of the N-methyl-d-aspartate (NMDA) subtype 
of glutamate receptors, but is also an agonist at the glu-
tamate binding site of this receptor. As NMDA receptors 
are up-regulated in alcohol-overconsuming individuals, 
because alcohol acts as an antagonist at NMDA receptors, 
elevated homocysteine plasma levels in actively drink-
ing patients may contribute to seizures in alcohol with-
drawal and explain the correlation between homocysteine 
plasma levels and the risk of withdrawal seizures (Bleich 
et al. 2006). Further, neuronal calcium influx mediated by 
effects of glutamatergic hyperexcitation of NMDA recep-
tors is a pathomechanism of Alzheimer’s disease and can 
induce cell death of retinal ganglion cells (Ganapathy  
et al. 2011). Thus, the rationale of this study is the assump-
tion that homocysteine impacts the electrophysiology of 
neurons as one underlying mechanism of the association 
of hyperhomocysteinemia with mild cognitive impairment 
and dementia (Chan et al. 2008; Stanger et al. 2009; Smith 
et al. 2010). In the present study, we aimed at elucidating 
acute and chronic effects of homocysteine on the excitabil-
ity of primary mouse hippocampal neurons.
Materials and methods
Patch-clamp recordings
Primary cultured neurons were superfused with an extra-
cellular solution containing (in mM) 125 NaCl, 3.5 KCl, 
1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, and 15 
d-glucose, osmolality 315 mOsm. Patch pipettes (resist-
ance 3–4 MΩ) were filled with an intracellular solution 
containing (in mM) 130 K-gluconate, 20 KCl, 10 HEPES, 
0.16 ethylene glycol-bis (2-aminoethyl ether)-N,N,N′,N′-
tetraacetic acid (EGTA), 2 Mg-adenosine 5′-triphosphate 
(ATP) and 2 Na2-ATP; pH was titrated to 7.25 with KOH; 
osmolality was adjusted to 295 mOsm using sucrose.
A liquid junction potential of −15 mV was measured 
between the intra- and extracellular solutions and corrected 
so that the data points were shifted in a hyperpolarizing 
direction relative to the voltage axis. We obtained tight-
seal whole-cell recordings with an EPC9 amplifier (HEKA, 
Lamprecht, Germany). Voltage signals were filtered at 
10 kHz (3 dB, four-pole low-pass Bessel filter) and sampled 
at 20 kHz or more by an interface (ITC16, Instrutech). All 
experiments were done at room temperature (21–23 °C).
Neuronal primary cell culture
Primary hippocampal neurons were prepared from Wistar 
rats as described previously (Schoch et al. 2001). Pregnant 
rats were killed, and the uterus containing the embryos 
(embryonic days 17–18) was removed. The hippocampus 
was isolated, and the tissue was washed and then digested 
with trypsin (0.025 g/ml for 10 min at 37 °C). After several 
washing steps, the tissue was dissociated by trituration using 
a plastic tip. The solution was centrifuged at 1,000 rpm for 
10 min, and medium was added. After counting, the cells 
were plated at a density of 40,000/24 well on glass cover-
slips coated with poly-l-lysine (Sigma-Aldrich). Neurons 
were cultured at 37 °C in a humidified incubator with 95 % 
air/5 %CO2 in basal medium eagle (BME) supplemented 
with 0.5 % glucose, 10 % fetal calf serum (FCS), 2 % 
B-27 and 0.5 mM l-glutamine (all Invitrogen, Karlsruhe, 
Germany) for 9–14 days before use.
Dissociated hippocampal neurons were incubated with 
100 μM homocysteine (DL-homocysteine, Sigma-Aldrich) 
for 24 h or were treated with acute intracellular applica-
tion of 100 μM homocysteine via inclusion into the patch 
pipette. This concentration is ten times higher than physio-
logical homocysteine plasma concentrations, but commonly 
observed in inborn errors of homocysteine metabolism, for 
example, due to deficiency of cystathionine beta-synthase 
or methylenetetrahydrofolate reductase. Also, severe vita-
min B12 deficiency can lead to such plasma concentrations 
(Stanger et al. 2009).
All neurons used in our experiments had a pyramidal 
neuron-like morphology with one or two major dendrites 
emanating from the cell body.
Analysis and statistics
The analysis of the recorded traces was performed by an 
automated algorithm using the software Igor (Wavemetrics). 
The activation threshold of action potentials was determined 
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as the point with the maximal increase in the slope. Param-
eters extracted from the traces were averaged, and unpaired 
Student’s t tests were performed for statistical comparison 
(Excel, Microsoft). The analysis was performed automated 
and blinded to avoid a bias. All data are presented as mean 
values, error bars represent the SEM. A significance level 
<0.05 is marked with asterisks throughout all figures. The 
number of recorded cells ranged from 10 to 20 (see figure 
legends for details).
Results
We obtained patch-clamp recordings from primary cultures 
of hippocampal neurons and first assessed the passive mem-
brane properties of these neurons. No significant differences 
between the resting membrane potential of the cells could 
be observed when comparing cells cultured under control 
conditions, following incubation with homocysteine or dur-
ing acute application of homocysteine (data not shown). We 
injected small subthreshold depolarizing currents to exam-
ine input resistance (Fig. 1a, inset). Fitting the subthresh-
old current–voltage relation allowed us to determine the 
input resistance (Fig. 1a). We found that preincubation with 
homocysteine (24 h, see “Methods”) caused a pronounced 
reduction in the input resistance by 42 % (Fig. 1b, from 529 
to 305 MΩ, n = 10 and 10, p < 0.05). In contrast, acute 
intracellular application of 100 μM homocysteine via inclu-
sion into the patch pipette did not affect input resistance 
(Fig. 1c, n = 17 and n = 16 for control and homocysteine). 
The apparent differences between the two control groups 
are due to variability between batches of cell cultures and 
consistently turned out to be not significant, whereas the 
comparison between control and application/incubation was 
always performed within one batch.
We next studied if the properties of action potentials are 
altered by homocysteine preincubation (Inc) or intracel-
lular application of homocysteine (IC). Individual action 
potentials were elicited by brief current injections (5 ms, 
lowermost trace in Fig. 2a) elicited firing of single action 
potentials (uppermost trace in Fig. 2a). The threshold for 
generation of an action potential was unaffected by homo-
cysteine, regardless of its mode of application (Fig. 2c), as 
was the action potential peak voltage (Fig. 2d), the time until 
the action potential peak was attained (Fig. 2e) and the dura-
tion of the action potential at threshold level (Fig. 2f). To 
examine spike afterpotentials, the depolarizing effects of the 
current injection were subtracted. To achieve this, we sub-
tracted the voltage trace elicited by just subthreshold current 
injection (middle trace in Fig. 2a) scaled to the size of the 
initial depolarization preceding the action potential (dashed 
line in Fig. 2b). This revealed an after spike hyperpolariza-
tion (lowermost trace in Fig. 2b), which was also not altered 
by homocysteine preincubation or intracellular application 
(Fig. 2g). Thus, it appears that neither application of homo-
cysteine via the patch pipette nor 24-h preincubation with 
homocysteine modifies the properties of individual action 
potentials.
We next studied the input–output relation of hippocam-
pal neurons, and if this can be affected by homocysteine. 
The input–output relation was assessed by injecting current 
pulses of various amplitudes (200 ms, Fig. 3a, b, lowermost 
traces) and counting the number of resultant action poten-
tials. We hypothesized that the decrease in input resistance 
seen in Fig. 1 would render homocysteine preincubated 
neurons less excitable and reduce action potential out-
put. Indeed, homocysteine preincubated cells generated 
significantly less action potential output for small current 
injections (100 and 150 pA, see Fig. 3c; asterisks indicate 
Fig. 1  Homocysteine effects on passive properties of hippocam-
pal neurons. a Photomicrograph of a representative neuronal culture 
on the left. Right panel shows input resistance calculated according 
to Ohm’s law from the current–voltage relation of passive voltage 
deflections (see inset, scale bars indicate 5 mV and 20 ms) elicited by 
small subthreshold current injections. b, c Preincubation with homo-
cysteine (Inc, open bars in b, n = 10), but not acute application of 
homocysteine (IC, open bars in c, n = 16), resulted in a decreased 
input resistance compared to control cells (filled bars in b, n = 10 
and c, n = 17)
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p < 0.05, n = 10 for homocysteine and control groups). 
Conversely, the application of homocysteine via the patch 
pipette did not affect the input–output relation (n = 17 and 
n = 16 for control and homocysteine, data not shown).
To characterize the shape of the action potentials and 
their activity-dependent change during action potential 
trains, we analyzed the first voltage trace that displayed 
five action potentials. The action potential firing displayed 
Fig. 2  Homocysteine does not affect the action potential shape. 
a Representative voltage trace of an action potential (upper trace) 
and a passive depolarization (middle trace, see lowermost part for 
current injections). Neither the action potential threshold (c), the 
minimum current injection needed to elicit an action potential (d), 
the peak voltage (d), the time to peak (e) nor the width of the action 
potential at threshold level (f) is altered following acute intracellular 
application (open bars, IC, n = 15) or 24-h incubation (open bars, 
Inc, n = 14) with 100 μM homocysteine compared to control cells 
(filled bars n = 16 (IC group) and 13 (Inc group)). b To analyze 
the afterpotentials of the action potential, the voltage trace elicited 
with a subthreshold current injection (a middle trace) was scaled 
to fit the passive phase of the action potential trace (a upper trace). 
The up-scaled subthreshold trace (dashed line) was subtracted from 
the action potential trace (full line) to correct the voltage trace 
for the artificial voltage deflection due to the experimental setup. 
The resulting trace (lowermost part) represents the active voltage 
changes during an action potential and reveals a pronounced after 
spike hyperpolarization. g The AHP was quantified in control cells 
(filled bars) and following intracellular application (IC) or 24-h 
incubation (Inc) with homocysteine (open bars) and was unaffected 
by homocysteine
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a frequency adaptation during the train in control conditions 
(see Fig. 4a). This adaptation turned out to be significant 
when quantified as increasing interspike intervals for all 
recorded control cells (as indicates by the arrow in Fig. 4a, 
see filled circles and asterisks in Fig. 4b, c). Following 24-h 
preincubation with homocysteine, this frequency adaptation 
was markedly reduced and no longer significant (open cir-
cles in Fig. 4b). This was not the case when homocysteine 
was introduced via the patch (open circles in Fig. 4c). Nei-
ther preincubation nor acute application of homocysteine 
affected the initial spike interval.
Action potentials physiologically broaden during a 
train of action potentials, reflecting the progressive inac-
tivation of voltage-gated ion channels (Fig. 5a). Spike 
broadening was quantified at the level of the half Ap 
amplitude (see dashed lines in Fig. 5b1, b2). The spike 
broadening during trains was significantly reduced in 
cells preincubated 24 h in homocysteine (open circles 
in Fig. 5c). In contrast to the homocysteine effects on 
input resistance and frequency adaptation, this loss of 
spike broadening was also exerted by acute application 
of homocysteine (open circles in Fig. 5d). These results 
show that long-term exposure to homocysteine strongly 
affects neuronal excitability, whereas short-term expo-
sure has only discrete effects.
Discussion
The present study aimed at analyzing electrophysiologi-
cal effects of homocysteine as a possible mechanism of the 
association between hyperhomocysteinemia and neurologi-
cal diseases.
We tested the effects of intra- and extracellular elevations 
of homocysteine concentrations on primary mouse neurons 
and observed that the input resistance decreases follow-
ing long-term homocysteine exposure. This phenomenon 
results in a decrease in the neuronal input–output relation, 
rendering the neurons less excitable to lower- and mid-range 
current injections. Further, we found a significant reduction 
in both spike broadening and frequency adaptation during 
repetitive firing following 24-h homocysteine incubation. 
While a reduction in input resistance may be interpreted as 
a reduction in excitability, this latter effect is consistent with 
an increased excitability, as spike accommodation limits the 
capability of cells to fire high-frequency discharges (Zhou 
and Hablitz 1996). These results indicate that the effects of 
homocysteine on neurons elude a simple classification into 
pro- and anti-excitatory effects.
Fig. 3  Reduced repetitive firing following homocysteine incuba-
tion. a Prolonged current injections (200 ms) of varying magnitude 
(50–400 pA) were applied to elicit repetitive action potential firing. 
b Representative voltage traces recorded in control cells (b1) and fol-
lowing incubation with homocysteine (b2). c The action potential fre-
quency for all cells was depicted versus the magnitude of the current 
injection. In control cells (filled circles, n = 10), the action potential 
firing rate increased initially with larger current injections (see also 
lower traces in b1). When further increasing the magnitude of the cur-
rent injection, the repolarization became insufficient, and the action 
potential firing was blocked (see uppermost traces in b1) resulting 
in reduced firing rates. In homocysteine-treated cells (open circles, 
n = 10), the firing rate following small current injections was signifi-
cantly smaller (see asterisks, p < 0.05). With larger current injections, 
the firing rate increased continuously without block due to insuffi-
cient repolarization (see also upper traces in b2)
◂
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Homocysteine is associated with vascular and neurode-
generative diseases, mechanisms are only poorly understood. 
This study suggests that interaction of homocysteine with 
electrophysiological properties of cells may be a relevant 
mechanism. It remains unclear whether interaction with ion 
channels or ions themselves is the reason. We have shown 
that homocysteine and copper interact probably by binding 
of copper by homocysteine (Linnebank et al. 2006). Thus, 
for the future, the channels and ions homocysteine is inter-
fering with, should be explored. As limitation, we used an 
artificial patch-clamp approach with experimental 24-h 
incubation or intracellular application of homocysteine, 
whereas toxicity of mild or severe hyperhomocysteinemia 
occurs over years and decades.
Alterations of biophysical properties of cells may arise 
from unspecific toxicity or apoptosis, and homocysteine 
has been reported to induced apoptosis of neurons even at 
low concentrations (50–250 μM, Ganapathy et al. 2011; 
Kruman et al. 2000). No degradation of cells was seen, and 
we selected cells in healthy conditions by visual inspection 
for our recordings, but we did not quantitatively evaluate 
the neuronal cultures for cell loss or changes in neuronal 
morphology. However, the functional changes were quite 
selective, with the resting membrane potential and most 
action potential properties being unaffected. We believe this 
argues against, but does not completely exclude, large toxic 
effects of homocysteine in our cultures.
As we aimed at analyzing toxicity of hyperhomocysteine-
mia as a chronic condition in humans, we did not analyze 
per-acute effects of homocysteine incubation, but incubated 
cells for 24 h before testing as a compromise. Homocysteine 
is not taken up by cells, but can be excreted to the extracel-
lular space (Fowler 2005). Thus, concerning intracellular 
application, we made analyses immediately, as intracellu-
lar concentrations after application were unpredictable and 
could not be monitored.
In patients, available evidence suggests that hyper-
homocysteinemia is associated with increased CNS  
excitability. For instance, hyperhomocysteinemia is a risk 
factor for epileptic seizures in alcohol-dependent patients 
under conditions of alcohol withdrawal (Bleich et al. 
2006). One explanation for this hyperexcitable phenotype 
in vivo may be that in intact neuronal networks, the pro-
excitatory effects of homocysteine dominate. Alternately, 
synaptic effects of homocysteine may become relevant. 
In the case of withdrawal seizures, NMDA receptors, 
which are inhibited by alcohol, are up-regulated in 
actively drinking patients. Homocysteine is both an ago-
nist at the glutamate binding site of the NMDA receptor 
complex and an antagonist at the glycine co-agonist site. 
This raises the possibility that homocysteine may exert 
NMDA agonistic actions, in particular, if glycine lev-
els in the CNS are increased (Lipton et al. 1997; Bleich  
et al. 2006).
Fig. 4  Homocysteine abol-
ishes the frequency adaptation 
of repetitive firing. a The first 
action potential train with 
at least 5 action potentials 
was analyzed to address the 
frequency adaptation during 
the train. Interspike intervals 
as indicated by the arrow were 
quantified. During the recorded 
period, a slight but signifi-
cant increase in the interspike 
interval was observed (filled 
circles in b, n = 10 and c, 
n = 17, p < 0.05, see asterisks). 
Following 24-h preincubation 
(Inc) with homocysteine, this 
frequency adaptation was abol-
ished (open circles in b, n = 10, 
not significant), but it was not 
affected by acute intracellular 
application (IC) of homocyst-
eine (c open circles, n = 16)
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Epilepsy is one of the most common neurological dis-
orders. In most cases, a lifetime therapy with antiepilep-
tic drugs (AED) is necessary. Despite development of a 
significant number of new AEDs, about 30 % of patients 
with epilepsy remain refractory to drug treatment (Regesta 
and Tanganelli 1999). Even though drug resistance is 
a significant clinical problem, the molecular and cellu-
lar mechanisms underlying the clinical phenomenon of 
drug resistance remain incompletely understood. Most 
AED are associated with decreased folate or vitamin B12 
plasma levels and thus dispose to hyperhomocysteinemia  
(Linnebank et al. 2011). Hyperhomocysteinemia due to 
AED long-term treatment may contribute to secondary 
pharmacoresistance observed in several patients with initial 
AED response. In addition, inhibitory and excitatory effects 
of hyperhomocysteinemia may contribute to long-term 
AED side effects on the central nervous system like fatigue 
and cognitive impairment in addition to the increased risk 
for ischemic heart disease (+34 %) and fatal cardiovascu-
lar disease (+68 %) in individuals with epilepsy (Gaitatzis  
et al. 2004).
In conclusion, our data describe heterogeneous electro-
physiological effects of homocysteine on neurons, some of 
which may contribute to neurological impairment and sei-
zures associated with hyperhomocysteinemia.
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Fig. 5  Spike broadening is 
reduced following incuba-
tion with homocysteine. a To 
address the spike broadening 
during the train, the same traces 
as in Fig. 3 were analyzed.  
b Action potential width was 
measured at half width level 
(dashed horizontal line) as 
depicted for the first (b1 as 
indicated in a) and last action 
potential (b2 as indicated in a). 
Width of all action potentials 
was normalized to the width 
of the first action potential, 
averaged for all cells. In control 
cells, the spikes broadened to 
the ~1.5 width of the first action 
potential (filled circles in c, 
n = 10 and d, n = 17). This 
broadening was significantly 
reduced following 24-h incuba-
tion (Inc) with homocysteine  
(c open circles, n = 10) or acute 
application (IC) of homocyst-
eine (d open circles, n = 16)
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